Evidence map›Paper›PMID 29750086›Full record

SynthesisDisease markers2018

Meng Zhang, Qianjun Liang, Ligang Zhang, Zongyao Hao, Jun Zhou, Li Zhang, Song Fan, Chaozhao Liang

Abstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Disease markers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Role of Genetic Variations inCancer genomics & proteomics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Meng ZhangDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID 0000-0001-5604-3745
Qianjun LiangDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Ligang ZhangDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zongyao HaoDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jun ZhouDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Li ZhangDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID 0000-0002-4891-7841
Song FanDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Chaozhao LiangDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID 0000-0003-2317-1323

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe conducted an update meta-analysis aiming to verify the association between

methodsRelevant studies were collected from diverse databases up to March 2017. In addition, a hospital-based (H-B) case-control study enrolling 90 PCa patients and 140 healthy controls was included to verify these evidence-based findings. Genetic risk was calculated by odds ratio (OR) with its corresponding 95% confidence interval (CI). The

resultsFinally, twenty-four published studies comprising 9627 cases and 12,102 controls were enrolled for the current meta-analysis. Overall analysis suggested that

conclusionAlthough evidence-based results suggest that

Indexed as

Polymorphism, Single NucleotideAsian PeopleCase-Control StudiesCyclin-Dependent Kinase Inhibitor p27HumansMaleProstatic NeoplasmsWhite PeopleCDKN1B protein, humanCyclin-Dependent Kinase Inhibitor p27

Identifiers

PMID29750086
PMCPMC5884233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.